Café

© 2026 Longbridge｜Terms of Service Privacy Policy

IMM

IMM

----

LongbridgeAI

Immutep shares are trading higher after the FDA granted the company Orphan Drug Designation for for eftilagimod alfa for the treatment of Soft Tissue Sarcoma

benzinga_article

Apr 15, 2026 at 12:05 PM

Immutep shares are trading higher after the FDA granted the company Orphan Drug Designation for for eftilagimod alfa for the treatment of Soft Tissue Sarcoma

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Immutep

USIMMP

-0.05%

Immutep Ltd

AUIMM